Tuesday, June 28, 2016

BRIEF-Auris Medical completes enrollment of Phase 3 TACTT3 trial

* Auris Medical completes enrollment of Phase 3 TACTT3 trial

with Keyzilen in acute and post-acute inner ear tinnitus

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)